drugset / Trial / NCT00857883

A First-Time-In-Human Study in Healthy Subjects

NCT00857883

Phase 1 Completed 56 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a first-time-in-human study. The overall purpose of the study is to assess whether the drug is safe and well tolerated after single, increasing doses. The blood levels of the drug after different doses will be measured and the effect of the drug on pleasurable eating behaviour will be assessed.

Timeline

Start
2008-11-17
Primary completion
2009-08-01
Completion
2009-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator GSK1521498 Small molecule

Indications